论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
胶质瘤相关癫痫非侵入性预测模型的开发与验证:列线图与决策树的比较分析
Authors Zhong Z, Yu HF, Tong Y, Li J
Received 17 December 2024
Accepted for publication 15 February 2025
Published 26 February 2025 Volume 2025:18 Pages 1111—1125
DOI https://doi.org/10.2147/IJGM.S512814
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Ching-Hsien Chen
Zian Zhong,* Hong-Fei Yu,* Yanfei Tong, Jie Li
Department of Neurology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Jie Li, Email zianzhongxys@163.com; Yanfei Tong, Email 1035608119@qq.com
Objective: Glioma-associated epilepsy (GAE) is a common neurological symptom in glioma patients, which can worsen the condition and increase the risk of death on the basis of primary injury. Given this, accurate prediction of GAE is crucial, and this study aims to develop and validate a GAE warning recognition prediction model.
Methods: We retrospectively collected MRI scan imaging data and urine samples from 566 glioma patients at the Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science from August 2016 to December 2023. Least Absolute Shrinkage and Selection Operator (LASSO) regression and multivariate logistic regression analysis are used to determine independent risk factors for GAE. The nomogram and decision tree GAE visualization prediction model were constructed based on independent risk factors. The discrimination, calibration, and clinical usefulness of GAE prediction models were evaluated through receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA), respectively.
Results: In the training and validation datasets, the incidence of GAE was 34.50% and 33.00%, respectively. Nomogram and decision tree were composed of five independent radiomic predictors and three differential protein molecules derived from urine. The discrimination rate of area under the curve (AUC) was 0.897 (95% CI: 0.840– 0.954), slightly decreased in the validation data set, reaching 0.874 (95% CI: 8.817– 0.931). The calibration curve showed a high degree of consistency between the predicted GAE probability and the actual probability. In addition, DCA analysis showed that in machine learning prediction models, decision trees have higher overall net returns within the threshold probability range.
Conclusion: We have introduced a machine learning prediction model for GAE detection in glioma patients based on multiomics data. This model can improve the prognosis of GAE by providing early warnings and actionable feedback and prevent or reduce pathological damage and neurobiochemical changes by implementing early interventions.
Keywords: glioma-associated epilepsy, multiomics, machine learning, prediction